Which hedge funds own LMAT? LEMAITRE VASCULAR INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in LMAT (LEMAITRE VASCULAR INC) in their Q2 2026 13F filings, worth $62.1m in total. The largest holder by portfolio weight is Tudor Investment at 0.0% of its book. 1 manager opened a new position this quarter: Point72 Asset Management LP.
8tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold LMAT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Tudor Investment | Q2 2026 | 0.0% | $8.5m | 88,915 | 168% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $16.3m | 169,502 | 22% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $9.1m | 8,500,000 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $16.2m | 15,250,000 | -23% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $3.6m | 37,402 | -71% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $4.1m | 42,833 | -56% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $3.5m | 36,464 | -56% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $863.1k | 8,994 | -83% | reduced |
How has hedge fund ownership of LMAT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $62.1m |
| Q1 2026 | 6 | $81.0m |
| Q4 2025 | 2 | $22.2m |
| Q3 2025 | 2 | $21.9m |
| Q2 2025 | 1 | $13.2m |
| Q1 2025 | 2 | $16.1m |
| Q4 2024 | 3 | $18.9m |
| Q3 2024 | 3 | $17.6m |
| Q2 2024 | 2 | $13.5m |
| Q1 2024 | 3 | $10.7m |
| Q4 2023 | 2 | $7.7m |
| Q3 2023 | 4 | $6.7m |
| Q2 2023 | 3 | $6.9m |
| Q1 2023 | 4 | $4.7m |
| Q4 2022 | 3 | $3.7m |
| Q3 2022 | 3 | $5.1m |
Counts every tracked manager that disclosed LMAT in that quarter's filing, including managers that have since stopped filing.